Table 2. Concordance of clinical data elements between source documents and EGASP database for five audit cycles, EGASP Thailand, 2015–2021.
| Data Characteristics | Concordance (%) | Cycle-1/2 | Cycle-2/3 | Cycle-3/4 | Cycle-4/5 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cycle-1 | Cycle-2 * | Cycle-3 | Cycle-4 | Cycle-5 | OR (CI) | Fisher exact P-value | OR (CI) | Fisher exact P-value | OR (CI) | Fisher exact P-value | OR (CI) | Fisher exact P-value | |
| (N = 70) | (N = 157) | (N = 85) | (N = 68) | **(N = 42) | |||||||||
| 1. EGASP number | 100 | 100 | 98.8 | 100 | 100 | N/A*** | 1.000 | 1.012 (0.989, 1.036) | 0.351 | 0.988 (0.966, 1.011) | 1.000 | N/A*** | 1.000 |
| 2. Visit Date (DD/MM/YYYY) | 100 | 99.4 | 98.8 | 100 | 100 | 1.006 (0.994, 1.019) | 1.000 | 1.005 (0.979, 1.032) | 1.000 | 0.988 (0.966, 1.011) | 1.000 | N/A*** | 1.000 |
| 3. Gender of sex partner | 90 | 94.9 | 98.8 | 98.5 | 95.2 | 0.948 (0.870, 1.034) | 0.245 | 0.960 (0.920, 1.003) | 0.166 | 1.003 (0.966, 1.041) | 1.000 | 1.035 (0.961, 1.114) | 0.557 |
| 4. Antibiotic use in the previous 2 weeks | 100 | 96.8 | 97.6 | 98.5 | 95.2 | 1.033 (1.004, 1.063) | 0.327 | 0.991 (0.949, 1.036) | 1.000 | 0.991 (0.948, 1.036) | 1.000 | 1.035 (0.961, 1.114) | 0.557 |
| 5. Urethral gram stain result (only GNID) | 97.1 | 99.4 | 100 | 100 | 100 | 0.978 (0.937, 1.020) | 0.226 | 0.994 (0.981, 1.006) | 1.000 | N/A*** | 1.000 | N/A*** | 1.000 |
| 6. Diagnosis at current visit | 95.7 | 93.6 | 97.6 | 97.1 | 100 | 1.022 (0.959, 1.090) | 0.759 | 0.959 (0.910, 1.011) | 0.223 | 1.006 (0.954, 1.061) | 1.000 | 0.971 (0.931, 1.012) | 0.524 |
| 7. Primary treatment for gonorrhea | 85.7 | 99.4 | 100 | 98.5 | 97.6 | 0.863 (0.783, 0.950) | <0.001 | 0.994 (0.981, 1.006) | 1.000 | 1.015 (0.986, 1.045) | 0.444 | 1.009 (0.955, 1.067) | 1.000 |
| 8. Presence of dual treatment for gonorrhea | 85.7 | 98.1 | 100 | 97.1 | 97.6 | 0.874 (0.792, 0.964) | 0.001 | 0.981 (0.960, 1.003) | 0.554 | 1.030 (0.989, 1.074) | 0.196 | 0.994 (0.934, 1.059) | 1.000 |
Abbreviations: N = total number of reviewed elements, ID = identification, GNID = gram negative intracellular diplococci, OR = Odds ratio, CI = Confidence interval
*Due to missing source documents in the clinical data, the number of clinical/epidemiology data records reviewed in Cycle 2 was 157 and the number of laboratory records reviewed was 162.
**Due to missing source documents in the clinical data, the number of clinical/epidemiology data records reviewed in Cycle 5 was 42 and the number of laboratory records reviewed was 46.
***No statistics are computed; variable is a constant.
Data from each cycle were collected in the following time periods: Cycle 1 (11/2015–6/2016), Cycle 2 (7/2016–11/2017), Cycle 3 (12/2017–10/2018), Cycle 4 (11/2018–10/2019) and Cycle 5 (11/2019–12/2020)